In conclusion, elevated ZDHHC9 expression was not only associated with unfavorable outcomes in individuals with BC but also exhibited a negative correlation with several innate immune cells, suggesting that ZDHHC9 may suppress the antitumor immune response in BC. The gene discussed is ZDHHC9; the disease is breast cancer.